Boulder, CO, United States of America

Christopher T Workman

This inventor holds 7 USPTO granted patents. Top assignees: Ribozyme Pharmaceuticals, Incorporated, Napro Biotherapeutics, Inc., Sirna Therapeutics, Inc.. Active years: 1994-2004.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Christopher T Workman. Retrieved from https://idiyas.com/inventor/christopher-t-workman

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 2.4

ph-index = 5

Forward Citations = 185(Granted Patents)


Location History:

  • Boulder, CO (US) (1994 - 2000)
  • Lyngby, DK (2001 - 2004)

Company Filing History:


Years Active: 1994-2004

Loading Chart...
7 patents (USPTO):Explore Patents

Title: The Innovations of Christopher T Workman

Introduction

Christopher T Workman is a notable inventor based in Boulder, Colorado. He has made significant contributions to the field of RNA research, holding a total of seven patents. His work has advanced the understanding and manipulation of RNA molecules, which are crucial in various biological processes.

Latest Patents

Among his latest patents is a method for the one-pot deprotection of RNA molecules. This innovative approach simplifies the process of modifying RNA, making it more efficient and accessible for researchers in the field.

Career Highlights

Throughout his career, Christopher has worked with prominent companies such as Ribozyme Pharmaceuticals, Incorporated and Napro Biotherapeutics, Inc. His experience in these organizations has allowed him to develop and refine his expertise in RNA technology.

Collaborations

Christopher has collaborated with esteemed colleagues, including Laurent Bellon and David Reginald Carver. These partnerships have fostered a productive environment for innovation and research.

Conclusion

Christopher T Workman is a distinguished inventor whose work in RNA technology has made a lasting impact on the field. His patents and collaborations reflect his commitment to advancing scientific knowledge and innovation.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…